Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC). Patients with recurrent lung cancer cases. Individuals requiring identification of suitable targeted therapy protocols.

Positive: Indicates a mutation that may respond well to targeted drugs. Negative: Indicates no mutation found, guiding the physician toward other therapies.

Book EGFR Mutation Test in Saudi Arabia | Lahalak Medical Platform

Identify the most effective treatment for lung cancer with EGFR mutation testing. This molecular analysis helps oncologists select targeted therapies that offer the best clinical outcomes for patients.

Scientific name: EGFR Mutation Analysis for NSCLC

A specialized molecular diagnostic test used to detect genetic mutations in the EGFR gene of lung cancer cells, enabling personalized selection of effective targeted therapies.

EGFR Mutation Analysis for NSCLC - Precision Targeted Lung Cancer Testing

Service type Molecular / Genetic Testing

Duration 3-7 working days

Fasting Fasting is not required

Included Services

Sample collection
Molecular analysis
Laboratory results report

Medical Service Information

Importance of the Test

Determining patient response to Tyrosine Kinase Inhibitors (TKIs).
Personalizing treatment plans based on the tumor's genetic profile.
Avoiding unnecessary chemotherapy when targeted mutations are present.

Target Groups

Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC).
Patients with recurrent lung cancer cases.
Individuals requiring identification of suitable targeted therapy protocols.

Interpreting Results

Positive: Indicates a mutation that may respond well to targeted drugs.
Negative: Indicates no mutation found, guiding the physician toward other therapies.